Cargando…
BNMS position statement on molecular radiotherapy
Autores principales: | Flux, Glenn, Buscombe, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445360/ https://www.ncbi.nlm.nih.gov/pubmed/34284439 http://dx.doi.org/10.1097/MNM.0000000000001458 |
Ejemplares similares
-
Clinical Trials and Molecular Radiotherapy
por: Buscombe, John R.
Publicado: (2015) -
BnMs3 is required for tapetal differentiation and degradation, microspore separation, and pollen-wall biosynthesis in Brassica napus
por: Zhou, Zhengfu, et al.
Publicado: (2012) -
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
por: Dizdarevic, S, et al.
Publicado: (2019) -
Opportunities for research in molecular radiotherapy
por: Flux, Glenn D, et al.
Publicado: (2017) -
The internal dosimetry user group position statement on molecular radiotherapy
por: Gear, Jonathan, et al.
Publicado: (2021)